UY30529A1 - Compuestos de 1h-quinolin-4-ona, procedimientos, usos y composiciones - Google Patents
Compuestos de 1h-quinolin-4-ona, procedimientos, usos y composicionesInfo
- Publication number
- UY30529A1 UY30529A1 UY30529A UY30529A UY30529A1 UY 30529 A1 UY30529 A1 UY 30529A1 UY 30529 A UY30529 A UY 30529A UY 30529 A UY30529 A UY 30529A UY 30529 A1 UY30529 A1 UY 30529A1
- Authority
- UY
- Uruguay
- Prior art keywords
- compounds
- quinolin
- procedures
- compositions
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La invencion se refiere a nuevos compuestos de 1H-quinolin-4-ona de formula (I), donde R1, R2, R3, R4 y R5 tienen diferente significado, y las sales farmacéuticamente aceptables e hidratos de los mismos. Los compuestos de formula (I) son utiles en el tratamiento o prevencion de enfermedades asociadas a la modulacion de los receptores GABAa, ansiedad, epilepsia, trastornos del sueno que incluyen insomnio e inducir sedadion -hipnosis, anestesia, sueno y relajacion muscular. La invencion también se refiere al procedimiento de síntesis para la preparacion de dichos compuestos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06118720A EP1886996A1 (en) | 2006-08-10 | 2006-08-10 | 1H-Quinolin-4-one compounds, with affinity for the GABA receptor, processes, uses and compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
UY30529A1 true UY30529A1 (es) | 2008-02-29 |
Family
ID=37651083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY30529A UY30529A1 (es) | 2006-08-10 | 2007-08-07 | Compuestos de 1h-quinolin-4-ona, procedimientos, usos y composiciones |
Country Status (13)
Country | Link |
---|---|
US (1) | US20100168099A1 (es) |
EP (1) | EP1886996A1 (es) |
CN (1) | CN101522630A (es) |
AR (1) | AR062295A1 (es) |
AT (1) | ATE512138T1 (es) |
BR (1) | BRPI0715817A2 (es) |
CL (1) | CL2007002324A1 (es) |
DK (1) | DK2064185T3 (es) |
PT (1) | PT2064185E (es) |
RU (1) | RU2009108361A (es) |
SI (1) | SI2064185T1 (es) |
TW (1) | TW200833665A (es) |
UY (1) | UY30529A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI366565B (en) | 2007-06-06 | 2012-06-21 | Otsuka Pharma Co Ltd | Quinolone compound and pharmaceutical composition |
TWI472525B (zh) * | 2008-12-05 | 2015-02-11 | Otsuka Pharma Co Ltd | 喹啉酮化合物及藥學組成物 |
JP5769504B2 (ja) * | 2010-06-04 | 2015-08-26 | 大塚製薬株式会社 | 医薬 |
KR20140138694A (ko) | 2012-02-03 | 2014-12-04 | 테바 파마슈티컬 인더스트리즈 리미티드 | 최선의 항-TNFα 요법에 실패한 크론병 환자를 치료하기 위한 라퀴니모드의 용도 |
TW201400117A (zh) | 2012-06-05 | 2014-01-01 | Teva Pharma | 使用拉喹莫德治療眼發炎疾病 |
TW201410244A (zh) * | 2012-08-13 | 2014-03-16 | Teva Pharma | 用於治療gaba媒介之疾病之拉喹莫德(laquinimod) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2728900B1 (fr) * | 1994-12-29 | 1997-01-31 | Synthelabo | Derives de 3-phenylisoquinolein-1(2h)-one, leur preparation et leur application en therapeutique |
GB9621757D0 (en) * | 1996-10-18 | 1996-12-11 | Ciba Geigy Ag | Phenyl-substituted bicyclic heterocyclyl derivatives and their use |
FR2813791B1 (fr) * | 2000-09-14 | 2004-03-12 | Lafon Labor | Utilisation de 2- et 4-quinolones pour inhiber la neo-proliferation intimale |
ES2319176T3 (es) * | 2002-05-14 | 2009-05-05 | The Regents Of The University Of California | Acidos quinolona-carboxilicos sustituidos, sus derivados, sitio de accion y uso de los mismos. |
-
2006
- 2006-08-10 EP EP06118720A patent/EP1886996A1/en not_active Withdrawn
-
2007
- 2007-08-06 TW TW096128818A patent/TW200833665A/zh unknown
- 2007-08-07 UY UY30529A patent/UY30529A1/es unknown
- 2007-08-09 PT PT07788348T patent/PT2064185E/pt unknown
- 2007-08-09 CL CL2007002324A patent/CL2007002324A1/es unknown
- 2007-08-09 CN CNA2007800365992A patent/CN101522630A/zh active Pending
- 2007-08-09 RU RU2009108361/04A patent/RU2009108361A/ru not_active Application Discontinuation
- 2007-08-09 DK DK07788348.6T patent/DK2064185T3/da active
- 2007-08-09 SI SI200730707T patent/SI2064185T1/sl unknown
- 2007-08-09 AT AT07788348T patent/ATE512138T1/de active
- 2007-08-09 US US12/377,103 patent/US20100168099A1/en not_active Abandoned
- 2007-08-09 AR ARP070103514A patent/AR062295A1/es unknown
- 2007-08-09 BR BRPI0715817-3A2A patent/BRPI0715817A2/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SI2064185T1 (sl) | 2011-10-28 |
BRPI0715817A2 (pt) | 2014-12-23 |
AR062295A1 (es) | 2008-10-29 |
CN101522630A (zh) | 2009-09-02 |
TW200833665A (en) | 2008-08-16 |
PT2064185E (pt) | 2011-09-12 |
EP1886996A1 (en) | 2008-02-13 |
ATE512138T1 (de) | 2011-06-15 |
CL2007002324A1 (es) | 2008-01-18 |
RU2009108361A (ru) | 2010-09-20 |
DK2064185T3 (da) | 2011-09-19 |
US20100168099A1 (en) | 2010-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CU20110145A7 (es) | Derivados de sulfonamida | |
PA8622001A1 (es) | Derivados de sulfonamida para el tratamiento de enfermedades | |
UY28752A1 (es) | Agentes terapeuticos | |
PA8627001A1 (es) | Compuestos para el tratamiento de enfermedades | |
CR8649A (es) | Derivados de formamidina para el tratamiento de enfermedades | |
CO6251367A2 (es) | Derivados de 6-amino-5-aril piridina-2il-carboxamida | |
UY30377A1 (es) | Inhibidores triciclicos fusionados de sulfonamida de gama-secretasa | |
UY27872A1 (es) | Inhibidores de caspasa y usos de los mismos. | |
UY30529A1 (es) | Compuestos de 1h-quinolin-4-ona, procedimientos, usos y composiciones | |
UY29618A1 (es) | " pirazolo(1,5-a) pirimidinas halogenadas, métodos, usos, composiciones e intermedios" | |
CO6382089A2 (es) | Compuestos,composiciones y metodos para el tratamiento de enfermadades causadas por un b-amiloide y sinucleinopatias | |
UY31159A1 (es) | Derivados de quinolina, métodos para su fabricación, composiciones farmacéuticas de los mismos y usos de los mismos | |
UY28993A1 (es) | Tetrahidroisoquinolinas sustituidas en calidad de inhibidores de mpm, procedimiento para su uso como medicamento.- | |
UY30521A1 (es) | Pirazolo[1,5-a] pirimidinas, procesos, usos y composiciones | |
DOP2009000121A (es) | Analogos de pirazol como inhibidores selectivos de 5-lo | |
NO20090971L (no) | 1H-quinolin-4-on forbindelser med affinitet for GABA-receptoren, fremgangsmater, anvendelser og sammensetninger | |
UY30066A1 (es) | Hidrazidas del acido imidazo(1,2-a) piridin-3-il-acético, procesos, usos y composiciones | |
AR068978A1 (es) | N-oxidos de venlafaxina y o-desmetilvenlafaxina como prodrogas | |
UY30249A1 (es) | Imidazo (1,2-b) piridazinas, procesos, usos intermedios y composiciones | |
ATE393148T1 (de) | Neue benzimidazolderivative und ihre pharmazeutische zusammensetzungen | |
UY28819A1 (es) | Derivados de formamida para el tratamiento de enfermedades | |
CL2008003141A1 (es) | Compuestos derivados de 1-(3-alcoxi-fenil)-pirrolidin-3-il-aminas aciladas con actividad en los receptores mt1 y mt2; composicion farmaceutica que los comprende; y uso en el tratamiento o prevencion de alteraciones melatoninergicas tales como depresion, alteraciones de sueño, diabetes, parkinson y alzheimer. | |
UY29311A1 (es) | Agentes terapeuticos | |
UY29310A1 (es) | Agentes terapéuticos | |
GT200500056A (es) | Compuestos utiles para el tratamiento de enfermedades |